Characterization of New Milk-derived Inhibitors of Angiotensin Converting Enzyme In Vitro and In Vivo

By Fuglsang Anders   Nilsson Dan   Nyborg Niels C.B.  

Journal of Enzyme Inhibition and Medicinal Chemistry, Vol. 18, Iss. 5, 2003-08 ,pp. : 407-412

Informa Healthcare

Access to resources Recommend Favorite

Synthesis and antimalarial activity of urenyl Bis-chalcone in vitro and in vivo

By Domínguez José N.   Gamboa de Domínguez Neira   Rodrigues Juan   Acosta María Eugenia   Caraballo Noris   León Caritza  

Journal of Enzyme Inhibition and Medicinal Chemistry, Vol. 28, Iss. 6, 2013-12 ,pp. : 1267-1273

Informa Healthcare

Access to resources Recommend Favorite

In vivo and in vitro effect of androstene derivatives as 5α-reductase type 1 enzyme inhibitors

By Bratoeff Eugene   Sánchez Araceli   Arellano Yazmín   Heuze Yvonne   Soriano Juan   Cabeza Marisa  

Journal of Enzyme Inhibition and Medicinal Chemistry, Vol. 28, Iss. 6, 2013-12 ,pp. : 1247-1254

Informa Healthcare

Access to resources Recommend Favorite

In vitro and in vivo metabolism of a novel cannabinoid-1 receptor inverse agonist, taranabant, in rats and monkeys

By Reddy V.B.G.   Doss G.A.   Karanam B.V.   Samuel K.   Lanza Jr T.J.   Lin L.S.   Yu N.X.   Zhang A.S.   Raab C.E.   Stearns R.A.   Kumar S.  

Xenobiotica, Vol. 40, Iss. 9, 2010-09 ,pp. : 650-662

Informa Healthcare

Access to resources Recommend Favorite

Prediction of in vivo drug interactions with eplerenone in man from in vitro metabolic inhibition data

By Cook C. S.   Berry L. M.   Burton E.  

Xenobiotica, Vol. 34, Iss. 3, 2004-03 ,pp. : 215-228

Informa Healthcare

Access to resources Recommend Favorite